Literature DB >> 15788411

A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cells.

Srikumar M Raja1, Sunil S Metkar, Stefan Höning, Baikun Wang, William A Russin, Nina H Pipalia, Cheikh Menaa, Mattias Belting, Xuefang Cao, Ralf Dressel, Christopher J Froelich.   

Abstract

The molecular interaction of secreted granzyme B-serglycin complexes with target cells remains undefined. Targets exposed to double-labeled granzyme B-serglycin complexes show solely the uptake of granzyme B. An in vitro model demonstrates the exchange of the granzyme from serglycin to immobilized, sulfated glycosaminoglycans. Using a combination of cell binding and internalization assays, granzyme B was found to exchange to sulfated glycosaminoglycans and, depending on the cell type, to higher affinity sites. Apoptosis induced by purified granzyme B and cytotoxic T-cells was diminished in targets with reduced cell surface glycosaminoglycan content. A mechanism of delivery is proposed entailing electrostatic transfer of granzyme B from serglycin to cell surface proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788411     DOI: 10.1074/jbc.M501181200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Authors:  Kirstin Veugelers; Bruce Motyka; Ing Swie Goping; Irene Shostak; Tracy Sawchuk; R Chris Bleackley
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

Review 3.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  Perforin oligomers form arcs in cellular membranes: a locus for intracellular delivery of granzymes.

Authors:  S S Metkar; M Marchioretto; V Antonini; L Lunelli; B Wang; R J C Gilbert; G Anderluh; R Roth; M Pooga; J Pardo; J E Heuser; M D Serra; C J Froelich
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

5.  Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection.

Authors:  Osama Sawesi; Dorothe Spillmann; Anna Lundén; Sara Wernersson; Magnus Åbrink
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

6.  Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic acid binding proteins.

Authors:  Marshall P Thomas; Jennifer Whangbo; Geoffrey McCrossan; Aaron J Deutsch; Kimberly Martinod; Michael Walch; Judy Lieberman
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

7.  Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells.

Authors:  Catherina H Bird; Jiuru Sun; Kheng Ung; Diana Karambalis; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Granzyme B delivery via perforin is restricted by size, but not by heparan sulfate-dependent endocytosis.

Authors:  Florian C Kurschus; Edward Fellows; Elisabeth Stegmann; Dieter E Jenne
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-04       Impact factor: 11.205

9.  Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1.

Authors:  Wendy A Boivin; Marlo Shackleford; Amanda Vanden Hoek; Hongyan Zhao; Tillie L Hackett; Darryl A Knight; David J Granville
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 10.  The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors.

Authors:  Tünde Szatmári; Katalin Dobra
Journal:  Front Oncol       Date:  2013-12-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.